Evaluation of fungal and bacterial contaminations of patient-used ocular drops.

The aim of the present study was to investigate the incidence of fungal and bacterial contaminations of in-use eye drop products in the teaching department of ophthalmology, Imam Khomeini Hospital, Ahvaz. Two hundred and eighty seven eye drop bottles were randomly collected at the end of day 1, day 2, day 3, day 4 and day 7 of use. The eye drop residues, swabs from internal caps and droppers were inoculated onto MacConkey agar, blood agar and Sabouraud's dextrose agar. The identification of the recovered organisms was accomplished using standard microbial identification techniques. The incidence of microbial contamination of in-use eye drop products was 17.8%, with the highest rate (24.6%) and the lowest rate (9.0%) noted with day 1 and day 3 samples, respectively. The most contaminated part of the eye drop products was the caps (45.9%) followed by droppers (41.0%) and residual contents (13.1%). Considering mendicants contents, those with pilocarpine (41.7%) had the highest rate of contamination followed by atropine (31.8%), tropicamide (28.6%) and betamethasone (23.3%). Our study revealed the potential risk of contamination of in-use eye drop products in hospitals, but we did not find a direct relationship between usage duration and contamination rate.

[1]  J. Wilson,et al.  Microbial contamination of preservative free eye drops in multiple application containers , 2006, British Journal of Ophthalmology.

[2]  M. M. Nishikawa,et al.  Indoor air microbiological evaluation of offices, hospitals, industries, and shopping centers. , 2005, Memorias do Instituto Oswaldo Cruz.

[3]  R. Silva,et al.  Monitoramento de fungos anemófilos e de leveduras em unidade hospitalar , 2005 .

[4]  M. J. Mendes-Giannini,et al.  [Monitoring of airborne fungus and yeast species in a hospital unit]. , 2005, Revista de saude publica.

[5]  B. Seitz,et al.  [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects]. , 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[6]  M. Fazeli,et al.  MICROBIAL CONTAMINATION OF PRESERVED OPHTHALMIC DROPS IN OUTPATIENT DEPARTMENTS: POSSIBILITY OF AN EXTENDED PERIOD OF USE , 2004 .

[7]  B. Seitz,et al.  Sterilitätskontrolle von unkonservierten Eigenserumtropfen bei therapieresistenten Hornhautepitheldefekten , 2004, Der Ophthalmologe.

[8]  P. Thomas.  Current Perspectives on Ophthalmic Mycoses , 2003, Clinical Microbiology Reviews.

[9]  P. Cuschieri,et al.  Ocular Infections due to Contaminated Solutions , 2001, Ophthalmologica.

[10]  H. Taşlı,et al.  Microbial contamination of eye drops. , 2001, Central European journal of public health.

[11]  V. Stone.  Environmental air pollution. , 2000, American journal of respiratory and critical care medicine.

[12]  K. O’Brien,et al.  Isolation and identification of Candida species from the oral cavity using Chromagar Candida , 2000 .

[13]  G. Hanlon,et al.  Evaluation of an extended period of use for preserved eye drops in hospital practice , 1998, The British journal of ophthalmology.

[14]  Donald C. Lehman,et al.  Textbook of Diagnostic Microbiology , 1997 .

[15]  J. Seltzer.  Building-related illnesses. , 1994, The Journal of allergy and clinical immunology.

[16]  K. Kenyon,et al.  Microbial contamination of in-use ocular medications. , 1992, Archives of ophthalmology.

[17]  H. Sjursen,et al.  BACTERIAL CONTAMINATION OF DROPS AND DROPPER TIPS OF IN‐USE MULTIDOSE EYE DROP BOTTLES , 1982, Acta ophthalmologica.